Introduction.-Although mevalonic acid has, in recent studies, been shown to be a very efficient precursor for squalene,'-3 cholesterol4 and other polyisoprene compounds,5' 6 the biosynthetic origin of mevalonate has not yet been described.
Previous work in this laboratory has demonstrated that f-hydroxy-fl-methyl glutaryl coenzyme A(HMG CoA)II can be formed in yeast and liver" by the condensation of acetyl CoA and acetoacetyl CoA. In view of the structural similarities of HMG CoA and mevalonate, it could be postulated that HMG CoA might be Biological synthesis of labeled fl-hydroxy-f-methyl glutaryl CoA: HMG-C'4-CoA was prepared by the condensation of acetyl-Cl4-CoA and acetoacetyl CoA in the presence of the purified yeast condensing enzyme.9 When acetyl-l-C'4-CoA was used as substrate, the C'4 was located in the free carboxyl group of the resulting HMG CoA7; with acetyl-2-C'4-CoA, the C'4 was in the methylene group adjacent to the free carboxyl group. Thus HMG-1-and HMG-2-C'4-CoA could conveniently be synthesized enzymatically. They were isolated by adsorption on charcoal, followed by paper chromatography. Chemical synthesis of labeled f3-hydroxy-f-methyl glutaryl CoA: Labeled HMGCoA from synthetic sources was prepared in the following manner. HMG-2-C'4 was synthesized from mevalonic-2-C'4 (Isotope Specialties Co.) by oxidation with permanganate at pH 6.6 . After addition of a large amount of nonisotopic mevalonate to dilute any residual mevalonate-2-C'4, HMG-2-C14 was isolated (free of mevalonate-2-C'4) using an acid celite column. 13 The labeled HMG was then converted to the anhydride by the method of Hilz et al.," recrystallized, and allowed to react with CoASH to form racemic HMG-2-C'4-CoA. The compound was isolated by paper chromatography in isobutyric acid: water: ammonia.
Enzymatic conversion of HMG-CoA to mevalonate: The conversion of HMG-C14-CoA to mevalonic acid was done with yeast extracts at room temperature in air. A large pool of nonisotopic mevalonate was added to trap any labeled mevalonate which was formed, and to serve as carrier for its isolation. C'4-mevalonate was isolated from reaction mixtures as the lactone by chromatography on acid celite,'3 using acid-equilibrated chloroform for elution. This method afforded good resolution of mevalonate, HMG, and acetate. Proportionality was excellent between the lactone as determined by titration and the C14 concentration in eluate fractions. Identity and purity of recovered mevalonate were further established by its derivatization as the dibenzylethylenediamine salt (m.p. 121-122°) and recrystalliza-tion to constant specific activity. In some cases, the recovered mevalonate-C"4 was oxidized to HMG-C14 with acid permanganate as further proof of identity. The yeast extracts contained the enzymes required for generation of TPNH from glucose-6-phosphate and TPN and DPNH from fructose-1,6-diphosphate and DPN.
Results.- Table 1 summarizes the results of two representative experiments in which HMG-C'4-CoA was incubated with yeast extracts. These data show a 100 Minoles unlabeled mevalonate, and where indicated 9 jmoles of DPN and 100 Mmoles of fructose-1,6-diphosphate as a DPNH generating system and/or 9 pmoles TPN and 100 Mmoles of glucose-6-phosphate as a TPNH generating system. Incubation time 2 hr, final volume was 13.7 ml. Mevalonate-C'4 counted as the recrystallized dibenzylethylene diamine salt. reasonably efficient conversion of HMG-C'4-CoA to mevalonate by the crude enzyme preparations. The activity of the enzyme preparation was markedly reduced by high-speed centrifugation, and further reduced by brief dialysis. The addition of a TPNH generating system restored and greatly augmented the conversion, while addition of a DPNH generating system only partially restored the activity. In experiments of this duration there was usually observed a 40-60 per cent conversion of total substrate to mevalonate when TPNH was the generated cofactor. Subsequent experiments have shown that TPNH added in substrate quantities could replace the TPNH generating system.
We have examined the possibility that HMG-C'4-CoA might first be broken down, and then be converted to mevalonic acid by an as yet unknown pathway. Two reactions have been described in which HMG CoA is enzymatically degraded. The first is by hydrolytic deacylation, as reported by Dekker et al.,"5 wherein free HMG and CoASH are produced. The second is by the cleavage reaction described by Bachhawat et al.,'4 in which HMG CoA is cleaved to acetyl CoA and acetoacetic acid. Table 2 summarizes experiments designed to evaluate the possible role of HMG, acetoacetate, and acetyl CoA in the biosynthesis of mevalonate. It can be seen that when HMG-C'4-CoA was hydrolyzed under alkaline conditions to free HMG and CoASH there was no incorporation of C14 into mevalonic acid. Acetoacetic acid likewise had no effect on the conversion of HMG-C "-CoA to mevalonate. Un-labeled acetyl CoA markedly depressed the level of radioactivity in mevalonate. The addition of acetyl-1-C'4-CoA however produced a similar depression suggesting an inhibition of the over-all reaction rather than dilution of the isotope. Furthermore, substitution of equivalent acetyl-1-C14-CoA for HMG CoA as substrate resulted in no detectable incorporation of C14 into mevalonate. In Experiment 3, Table 2 , it was found that the addition of CoASH to a system which converts HMG-2-C14-CoA to mevalonate resulted in a depression of the conversion. Expt. 2.-Where indicated, 0.05 pmole of biosynthetic HMG CoA was present (50,000 cpm). All flasks contained TPN and glucose-6-phosphate. Incubation, supplemental additions, and isolation were as indicated in Table 1. Expt. 3-Each flask contained 50 ,moles glucose-6-phosphate, 4.5 pmole TPN, 75 jsmoles Mg++, 300 ,umoles nicotinamide, 300 jmoles potassium phosphate buffer, pH 7.6. 120 mg of yeast protein (crude toluene lysate). From these results it would appear that HMG, acetoacetate, and acetyl CoA are not direct precursors of mevalonate but that HMG must be activated to HMG CoA before it can be converted to mevalonate. Furthermore, there is an apparent inhibition of the conversion of HMG CoA to mevalonate by free CoASH and some thiol esters of CoASH.
In order to establish whether the free carboxyl group or the thiol-esterified carboxyl group of HMG CoA was reduced in the conversion to mevalonate, biosynthetic labeled HMG CoA was incubated with the yeast enzyme and the TPNH generating system as outlined in Table 1 . The mevalonate was converted to the barium salt and subjected to pyrolysis under vacuum at 5000. CO2 obtained from the residual BaCO3 provided a sample of the carboxyl group of mevalonate. It was found that mevalonate obtained from HMG-1-C14-CoA yielded C1402, while the C02 from HMG-2-C14-CoA was unlabeled. These results show that the free carboxyl group of HMG CoA remains intact during the reduction, and consequently that the reduction occurs of the thiol-esterified group of HMG CoA, as indicated in Reaction 1.
It is of interest that if allowance is made for the fact that synthetic HMG CoA consists of at least 50 per cent of the unnatural optical isomers of HMG CoA the conversion to mevalonate (Experiment 1, Table 2 ) was almost as good as with enzymatically generated HMG CoA. Dituri et al. '6 reported that labeled HMG CoA made by the procedure of Bachhawat et al.'4 was not incorporated by liver preparations into squalene. In view of the fact that mevalonate can be readily converted to squalene we are unable to explain the failure to obtain incorporation. There is a possibility that the liver preparations may contain the HMG CoA cleavage"4 and deacylating" enzymes which would tend rapidly to destroy HMG CoA. These enzymes do not appear to be present to any great extent in our yeast preparations.
In order to establish whether the reduction of HMG CoA to mevalonic acid could be reversed, mevalonate-2-C"4 (1 umole, 500,000 cpm) was incubated with TPN, CoASH, oxidized glutathione, and yeast extract. Since there is a large amount of glutathione reductase in this enzyme preparation, it was expected that glutathione would favor HMG CoA formation through reoxidation of the TPNH formed in the oxidation of the mevalonate. However, no isotope could be detected in carrier HMG CoA, indicating that the reaction is not readily reversible. 
